Randal D Chase's Net Worth
-$33.6 Thousand
Who is Randal D Chase?
Randal D Chase does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include GeoVax Labs, Inc., and BIOJECT MEDICAL TECHNOLOGIES INC.
SEC CIK
Randal D Chase's CIK is 0001078784
Past Insider Trading and Trends
2007 was Randal D Chase's most active year for acquiring shares with 5 total transactions. Randal D Chase's most active month to acquire stocks was the month of May. 2006 was Randal D Chase's most active year for disposing of shares, totalling 2 transactions. Randal D Chase's most active month to dispose stocks was the month of May. 2020 saw Randal D Chase paying a total of $83,065.00 for 33,226 shares, this is the most they've acquired in one year. In 2008 Randal D Chase cashed out on 31,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GeoVax Labs, Inc. (GOVX) Snapshot price: $3.26
InvestorRandal D Chase owns 36,613 units of Common Stock which is worth $119,358.38. From 2021 to 2024 Randal D Chase acquired a total of 76,613 shares in GeoVax Labs, Inc. at a cost of $113,164.50.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
| +37.58% | 10K |
$1.10 | $11,000.00 | 36.61K |
Sep 21
| |||
Form 4
| +60.19% | 10K |
$1.21 | $12,100.00 | 26.61K |
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 11
| |||
Form 4
|
∞
| 16.61K |
$5.00 | $83,065.00 | 16.61K |
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
| +33.33% | 10K |
$0.19 | $1,899.50 | 40K |
May 5
| |||
Form 4
|
∞
| 30K |
$0.17 | $5,100.00 | 30K |
Apr 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BIOJECT MEDICAL TECHNOLOGIES INC No price found
InvestorRandal D Chase owns 42,500 units of Common Stock and 92,500 units of BJCT Common Stock.acquired a total of 106,250 shares in BIOJECT MEDICAL TECHNOLOGIES INC at a cost of $39,784.96.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +25.85% | 19K |
—
|
—
| 92.5K |
Jun 5
| |||
Form 4
| +34.86% | 19K |
—
|
—
| 73.5K |
Dec 5
| |||
Form 4
| +22.02% | 12K |
—
|
—
| 66.5K |
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
| +28.24% | 12K |
—
|
—
| 54.5K |
Dec 14
| |||
Form 4
| +30.77% | 10K |
$1.36 | $13,594.96 | 42.5K |
Jun 14
| |||
Form 4
| +17.12% | 4.75K |
—
|
—
| 32.5K |
May 24
| |||
Form 4/A
| +20.65% | 4.75K |
—
|
—
| 27.75K |
Nov 27
| |||
Form 4
| +22.09% | 4.75K |
—
|
—
| 26.25K |
Nov 27
| |||
Form 4
| +230.77% | 15K |
$1.35 | $20,190.00 | 21.5K |
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
∞
| 5K |
$1.20 | $6,000.00 | 5K |
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |